ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
127.678,05
-0,06%
S&P 500
5.309,43
0,02%
US Dollar vs BRL
5,1088
0,08%
Bitcoin
69.840,96
-2,25%
Brent Oil
82,315
-1,45%
Registration Strip Icon for pro Negocie como um profissional: Aproveite discussões em tempo real e ideias que movimentam o mercado para superar a concorrência.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. PharmaCyte Biotech Inc (PMCB)

  7. PharmaCyte Biotech Inc (PMCB) Notícias

PMCB

PharmaCyte Biotech (PMCB)

PharmaCyte Biotech Inc
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:PMCB
DataHoraFonteTítuloCódigoCompanhia
21/05/202410:00Business WirePharmaCyte Biotech Makes $7 Million Strategic Investment in MyMD, A Biopharmaceutical Company Focused on Inflammatory DiseaseNASDAQ:PMCBPharmaCyte Biotech Inc
14/02/202417:38Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:PMCBPharmaCyte Biotech Inc
06/02/202411:56Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:PMCBPharmaCyte Biotech Inc
15/12/202319:25Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:PMCBPharmaCyte Biotech Inc
28/11/202319:06Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:PMCBPharmaCyte Biotech Inc
24/11/202318:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PMCBPharmaCyte Biotech Inc
22/11/202319:02Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PMCBPharmaCyte Biotech Inc
22/11/202318:00Edgar (US Regulatory)Form SC 13D - General statement of acquisition of beneficial ownershipNASDAQ:PMCBPharmaCyte Biotech Inc
15/11/202310:30Business WirePharmaCyte Biotech Acquires $5 Million Stake in Emerging Women’s Health Innovator Femasys, Inc.NASDAQ:PMCBPharmaCyte Biotech Inc
31/10/202310:15Business WirePharmaCyte Biotech Provides Corporate Update on Cell-in-a-Box TechnologyNASDAQ:PMCBPharmaCyte Biotech Inc
02/10/202301:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:PMCBPharmaCyte Biotech Inc
21/09/202318:04Edgar (US Regulatory)Form S-3/A - Registration statement under Securities Act of 1933: [Amend]NASDAQ:PMCBPharmaCyte Biotech Inc
15/09/202318:00Edgar (US Regulatory)Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSBNASDAQ:PMCBPharmaCyte Biotech Inc
31/07/202318:18Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:PMCBPharmaCyte Biotech Inc
31/07/202317:42Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:PMCBPharmaCyte Biotech Inc
19/07/202311:28Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:PMCBPharmaCyte Biotech Inc
16/06/202318:23Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:PMCBPharmaCyte Biotech Inc
15/06/202317:02Edgar (US Regulatory)Amended Tender Offer Statement by Issuer (sc To-i/a)NASDAQ:PMCBPharmaCyte Biotech Inc
15/06/202310:15Business WirePharmaCyte Biotech Announces Final Results of Tender OfferNASDAQ:PMCBPharmaCyte Biotech Inc
05/06/202317:06Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:PMCBPharmaCyte Biotech Inc
25/05/202318:14Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)NASDAQ:PMCBPharmaCyte Biotech Inc
19/05/202318:20Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:PMCBPharmaCyte Biotech Inc
11/05/202309:30Business WirePharmaCyte Biotech Announces Cash Tender Offer for up to 7,750,000 Shares at $3.25 Per ShareNASDAQ:PMCBPharmaCyte Biotech Inc
16/03/202317:43Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:PMCBPharmaCyte Biotech Inc
14/02/202318:52Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:PMCBPharmaCyte Biotech Inc
02/02/202311:16Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:PMCBPharmaCyte Biotech Inc
02/02/202311:00Business WirePharmaCyte Biotech to Implement Second $10-Million Share Repurchase PlanNASDAQ:PMCBPharmaCyte Biotech Inc
30/12/202218:06Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:PMCBPharmaCyte Biotech Inc
30/12/202218:06Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:PMCBPharmaCyte Biotech Inc
11/10/202205:45TipRanksH.C. Wainwright Keeps Their Hold Rating on PharmaCyte Biotech (PMCB)NASDAQ:PMCBPharmaCyte Biotech Inc
 Apresentando as notícias mais relevantes sobre:NASDAQ:PMCB

Seu Histórico Recente

BOV
IBOV
Índice Bovespa
BOV
PDGR3
PDG REALT ON
BOV
HAGA3
HAGA ON
BOV
PRIO3
PETRORIO ON
BOV
COGN3
COGNA ON
BOV
SGPS3
SPRINGS ON
BOV
BHIA3
Grupo Casas Bahia ON
BOV
INBR32
Inter &
BOV
MGLU3
MAGAZINE LUIZA ON
BOV
HBOR3
HELBOR ON
BOV
JHSF3
JHSF PART ON
BOV
HOOT4
HOTEIS OTHON PN
BOV
IFCM3
Infracommerce Caxaas ON
BOV
LUPA3
LUPATECH ON
BOV
CASH3
Meliuz S.A ON
BOV
GOLL4
GOL PN
Delayed Upgrade Clock
ADVFN Logo

Brasil
Empresa
Negócios
Popular
Obter o aplicativo

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados